April 19, 2013
CCA Announces Resignation of Chief Executive Officer Andrew Spiegel
WASHINGTON, D.C., (April 19, 2013) —As the Colon Cancer Alliance (CCA) announces the resignation of its Chief Executive Officer, Andrew Spiegel, they offer immense thanks for his dedication and leadership. Spiegel’s history with the organization dates back to its founding days, when he was among the small group who formed the nation’s first patient advocacy organization dedicated to colon cancer. This group went on to become the CCA, where Spiegel served on the Board of Directors for nearly eight years before being appointed to the position of Chief Executive Officer (CEO) in 2009.
Under Spiegel, the CCA has grown from a small non-profit with just five employees and four programs to become the nationally-recognized voice for colon cancer patients.
In his four and a half years as CEO, the CCA has implemented more than a dozen programs to serve the needs of the colon cancer community through education, screening and patient-support campaigns. New programs like the Blue Note Fund, the Clinical Trials Matching Service, National Dress in Blue Day, the Stars Go Blue Benefit Concert, the Community Partnership Grants Program and the recently launched CCA Research Program, have lead the organization to further its mission to eradicate colon cancer and to provide high-quality programs to those directly affected by the disease.
While Spiegel was the CEO, the CCA saw a dramatic increase in the number of users of its services. In 2012 alone, the CCA provided information and services to more than 650,000 people and the organization is on track to reach more than one million people in 2013. Recently, the organization launched a new PSA featuring the CCA’s newest celebrity ambassador, Terrence Howard. In addition, more than $14 million was raised and used to support countless people throughout the patient community. Most recently, the CCA was honored to learn it has achieved a 4-star Charity Navigator rating, something very few non-profits can claim. In addition, the CCA’s popular Undy 5000 5K series grew from three races in 2008 to more than 20 events this year.
Spiegel’s right-hand woman, Jasmine Greenamyer, has stepped up as Interim CEO while the organization conducts a search for its new leadership. “Jasmine is the backbone of the CCA and is directly responsible for much of the organization’s growth. The transition of responsibilities to her has been seamless and the organization will continue to flourish under her very capable leadership,” says Spiegel. “For me, I am looking forward to spending more time with my three kids, traveling less and staying involved with the cause wherever possible. Having lost my mother to colon cancer nearly 14 years ago, I remain just as committed as ever to prevent the suffering caused by this very preventable disease. I plan to be involved with this cause for as long as I can help.”
During Spiegel’s tenure as CEO, the CCA worked closely with its European counterpart, EuropaColon, to launch the Global Colon Cancer Alliance (GCCA), an international colon cancer patient advocacy organization which is fighting the disease worldwide. Spiegel will remain Co-Executive Director of the GCCA where he will use his leadership and skills to grow the global organization at a time when the disease is rapidly growing in emerging countries.
“For Andy, colon cancer advocacy has always been personal and contagious,” says Greenamyer. “His dedication has been inspirational and our staff and community are proud of his impact. We know he’ll continue to be a force of nature and we wish him all the best in his next endeavor.”